Tag: medical literature

Hydroxychloroquine Has No Benefit, ‘Only Risks’ in COVID-19

Hydroxychloroquine and chloroquine, with or without azithromycin or clarithromycin, offer no benefit in treating patients with COVID-10 and, instead, are associated with ventricular arrhythmias and...

Risks Posed by COVID-19-Infected Bodies Remain Unclear

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s  Coronavirus Resource Center. As the coronavirus death toll has risen around the world, it...

First Vaccine Data, Antibody Test Issues

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Here are the coronavirus stories Medscape’s editors around the globe think...

FDA Approves Chemo-Free Combo for Lung Cancer

The US Food and Drug Administration (FDA) today approved the combination of nivolumab (Opdivo, Bristol-Myers Squibb) plus ipilimumab (Yervoy, Bristol-Myers Squibb) as first-line treatment for...

COVID-19 Daily: Antiviral Combo, Hospital Volumes

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Here are the coronavirus stories Medscape’s editors around the globe think...

Neoadjuvant Nivolumab ‘Promising’ in Merkel Cell Carcinoma

Neoadjuvant nivolumab (Opdivo, Bristol-Myers Squibb) could improve outcomes for patients with high-risk resectable Merkel cell carcinoma (MCC), say researchers reporting the first trial in this...

New Angiotensin Studies in COVID-19 Give More Reassurance

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Four more studies of the relationship of angiotensin-converting enzyme (ACE) inhibitors...

Cardiac Arrests Out-of-Hospital Soar During COVID-19 in Italy

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s  Coronavirus Resource Center. Out-of-hospital cardiac arrests increased 58% during the peak of the COVID-19...

CMS to Pay Clinicians Who Join COVID-19 Trials With MIPS Credit

Eligible clinicians who participate in Medicare’s Quality Payment Program, including physicians and midlevel practitioners, can earn credit in the Merit-based Incentive Payment System (MIPS) for...

Cognitive Decline With Endocrine Tx for Breast Ca

Cognitive impairment seen in women with early breast cancer who undergo chemotherapy ― so-called chemobrain ― has now been reported in patients who are treated...

NEJM Remdesivir Article Divides Twitter

What your doctor is reading on Medscape.com: APRIL 13, 2020 — New data published in the New England Journal of Medicine about the investigational antiviral drug remdesivir...

Encorafenib Now Approved for BRAF-Positive Colorectal Cancer

The targeted agent encorafenib (Braftovi, Array BioPharma, now part of Pfizer) has been approved by the US Food and Drug Administration (FDA) for use in...